NTRK1 and gastrointestinal stromal tumor: The immunohistochemistry staining of Pan-TRK, next-generation sequencing or fluorescence in situ hybridization have been used to screen NTRK fusions in a few cases of wild-type GIST, and each technique has its advantages and drawbacks.